Copyright
©The Author(s) 2021.
World J Gastroenterol. Nov 14, 2021; 27(42): 7387-7401
Published online Nov 14, 2021. doi: 10.3748/wjg.v27.i42.7387
Published online Nov 14, 2021. doi: 10.3748/wjg.v27.i42.7387
Figure 5 Endoscopically inserted liquid fiducials and liquid fiducial-based image-guided radiotherapy.
A: An Fluorodeoxyglucose positron emission tomography of a patient with oesophageal cancer which demonstrates no uptake within the lesion; B: Planning computerized tomography (CTs) showing the fiducials without and with the high dose clinical target volume (CTV) (pink); C: Planning CTs showing the fiducials without and with the low dose CTV (yellow); D: Cone-beam CT (CBCT) images that are not labelled; E: CBCT images that are labelled.
- Citation: Be KH, Khor R, Lim Joon D, Starvaggi B, Chao M, Ng SP, Ng M, Zorron Cheng Tao Pu L, Efthymiou M, Vaughan R, Chandran S. Long-term clinical outcomes of lipiodol marking using standard gastroscopy for image-guided radiotherapy of upper gastrointestinal cancers. World J Gastroenterol 2021; 27(42): 7387-7401
- URL: https://www.wjgnet.com/1007-9327/full/v27/i42/7387.htm
- DOI: https://dx.doi.org/10.3748/wjg.v27.i42.7387